Auris Medical Holding Ltd is a biotechnology business based in the US. Auris Medical Holding shares (EARS) are listed on the NASDAQ and all prices are listed in US Dollars. Auris Medical Holding employs 8 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Auris Medical Holding
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – EARS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Auris Medical Holding stock price (NASDAQ: EARS)Use our graph to track the performance of EARS stocks over time.
Auris Medical Holding shares at a glance
|Latest market close||$3.59|
|52-week range||$0.73 - $5.54|
|50-day moving average||$3.31|
|200-day moving average||$3.39|
|Wall St. target price||$14.95|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.33|
Buy Auris Medical Holding shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Auris Medical Holding stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Auris Medical Holding price performance over time
|1 week (2021-07-20)||N/A|
|1 month (2021-07-01)||0.56%|
|3 months (2021-04-30)||1.41%|
|6 months (2021-01-27)||N/A|
|1 year (2020-07-27)||N/A|
|2 years (2019-07-27)||N/A|
|3 years (2018-07-27)||N/A|
|5 years (2016-07-27)||N/A|
Auris Medical Holding financials
|Gross profit TTM||$174,475|
|Return on assets TTM||-21.99%|
|Return on equity TTM||-71.91%|
|Market capitalisation||$39.2 million|
TTM: trailing 12 months
Shorting Auris Medical Holding shares
There are currently 150,091 Auris Medical Holding shares held short by investors – that's known as Auris Medical Holding's "short interest". This figure is 125.7% up from 66,514 last month.
There are a few different ways that this level of interest in shorting Auris Medical Holding shares can be evaluated.
Auris Medical Holding's "short interest ratio" (SIR)
Auris Medical Holding's "short interest ratio" (SIR) is the quantity of Auris Medical Holding shares currently shorted divided by the average quantity of Auris Medical Holding shares traded daily (recently around 1.9 million). Auris Medical Holding's SIR currently stands at 0.08. In other words for every 100,000 Auris Medical Holding shares traded daily on the market, roughly 80 shares are currently held short.
However Auris Medical Holding's short interest can also be evaluated against the total number of Auris Medical Holding shares, or, against the total number of tradable Auris Medical Holding shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Auris Medical Holding's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Auris Medical Holding shares in existence, roughly 10 shares are currently held short) or 0.0124% of the tradable shares (for every 100,000 tradable Auris Medical Holding shares, roughly 12 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Auris Medical Holding.
Find out more about how you can short Auris Medical Holding stock.
Auris Medical Holding share dividends
We're not expecting Auris Medical Holding to pay a dividend over the next 12 months.
Have Auris Medical Holding's shares ever split?
Auris Medical Holding's shares were split on a 1:20 basis on 30 April 2019. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Auris Medical Holding shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Auris Medical Holding shares which in turn could have impacted Auris Medical Holding's share price.
Auris Medical Holding share price volatility
Over the last 12 months, Auris Medical Holding's shares have ranged in value from as little as $0.7255 up to $5.54. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Auris Medical Holding's is 1.4048. This would suggest that Auris Medical Holding's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Auris Medical Holding overview
Auris Medical Holding Ltd. , a clinical-stage biopharmaceutical company, developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy, and CNS disorders. The company's Phase 3 programs under the development include Keyzilen (AM-101) for the treatment of acute inner ear tinnitus; and Sonsuvi (AM-111) for the treatment of acute inner ear hearing loss. It is also developing AM-125 that is in Phase 2 clinical trial for the intranasal treatment of acute peripheral vertigo; AM-201, which has completed Phase 1b clinical trial for the prevention of antipsychotic induced weight gain and drowsiness; and AM-301, a drug-free nasal spray for protection against airborne viruses and allergens, as well as AM-102 for the tinnitus treatment. The company has a collaboration and license agreement with INSERM; and Xigen S. A. to develop, manufacture, and commercialize pharmaceutical products, as well as drug delivery devices and formulations for local administration of therapeutic substances to the inner ear for the treatment of ear disorders.
Stocks similar to Auris Medical Holding
Auris Medical Holding in the news
Four new option listings and four option delistings on July 26th
Auris Medical Announces Launch of New Corporate Website
Auris Medical Announces Launch of New Corporate Website
Frequently asked questionsWhat percentage of Auris Medical Holding is owned by insiders or institutions?
Currently 5.445% of Auris Medical Holding shares are held by insiders and 5.585% by institutions. How many people work for Auris Medical Holding?
Latest data suggests 8 work at Auris Medical Holding. When does the fiscal year end for Auris Medical Holding?
Auris Medical Holding's fiscal year ends in December. Where is Auris Medical Holding based?
Auris Medical Holding's address is: Clarendon House, Hamilton, Bermuda, HM 11 What is Auris Medical Holding's ISIN number?
Auris Medical Holding's international securities identification number is: BMG070252017 What is Auris Medical Holding's CUSIP number?
Auris Medical Holding's Committee on Uniform Securities Identification Procedures number is: G07025102
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert